What's breaking now, across thousands of outlets.
Bis zu 2,88 Milliarden Dollar gibt der Pharmakonzern für die Übernahme der Biotechfirma Merida Biosciences aus. Finanziert wird der Kauf mit den Milliarden aus dem Abnehmspritzen-Boom.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.
In today's Pharmalittle newsletter, drug pricing deals, a new cancer therapy approval, and more of the latest pharma headlines.
A Monte Carlo-based 4D dose calculation framework assesses the uncertainties for realistic clinical treatments The post Dose calculations reveal how patient motion impacts proton minibeam therapy…
A group of academic researchers genetically engineered Alteromonas macleodii , a widespread marine bacterium, to produce more siderophores, accelerating olivine weathering 2.6-fold in seawater…
In the search for new treatments and even a cure for hepatitis B, two Brazilian public universities have joined forces with international institutions.
Stockholm-based HealthTech company Elekta has secured a loan of up to €100 million from the European Investment Bank (EIB), the European Union’s financing arm.
